References
- Hellstein JW, Marek CL. Bisphosphonate osteochemonecrosis (bisphossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 2005;63:682-9. https://doi.org/10.1016/j.joms.2005.01.010
- Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007;22:1479-91. https://doi.org/10.1359/jbmr.0707onj
- Marx RE. Oral & intravenous bisphosphonate-induced osteonecrosis of the jaws: history, etiology, prevention, and treatment. Hanover Park: Quintessence Publishing; 2007:1-65.
- Correia Vde F, Caldeira CL, Marques MM. Cytotoxicity evaluation of sodium alendronate on cultured human periodontal ligament fibroblasts. Dent Traumatol 2006;22:312-7. https://doi.org/10.1111/j.1600-9657.2005.00434.x
- Filleul O, Crompot E, Saussez S. Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol 2010;136:1117-24. https://doi.org/10.1007/s00432-010-0907-7
- Kim KM, Rhee Y, Kwon YD, Kwon TG, Lee JK, Kim DY. Medication related osteonecrosis of the jaw: 2015 position statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons. J Bone Metab 2015;22:151-65. https://doi.org/10.11005/jbm.2015.22.4.151
- Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007;65:369-76. https://doi.org/10.1016/j.joms.2006.11.003
- Solomon DH, Mercer E, Woo SB, Avorn J, Schneeweiss S, Treister N. Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges. Osteoporos Int 2013;24:237-44. https://doi.org/10.1007/s00198-012-2042-6
- Casal C, Someso E, Alvarez AM, Farina J, Alvarez T. Osteonecrosis de maxilares relacionada con el uso de bifosfonatos [Osteonecrosis of the jaws related with the use of bisphosphonates]. Farmaceuticos de Atencion Primaria 2012;10:9-14. https://doi.org/10.1016/S2172-3761(12)70050-X
- Varun B, Sivakumar T, Nair BJ, Joseph AP. Bisphosphonate induced osteonecrosis of jaw in breast cancer patients: a systematic review. J Oral Maxillofac Pathol 2012;16:210-4. https://doi.org/10.4103/0973-029X.98893
- Lee JK, Kim KW, Choi JY, Moon SY, Kim SG, Kim CH, et al. Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report. J Korean Assoc Oral Maxillofac Surg 2013;39:9-13. https://doi.org/10.5125/jkaoms.2013.39.1.9
- Chang JI, Hazboun RC, Chang TI. Incongruities in the AAOMS position paper: medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg 2014;72:2381.
- Kos M. Incidence and risk predictors for osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. Arch Med Sci 2015;11:319-24.
- Arce C, Bargallo E, Villasenor Y, Gamboa C, Lara F, Perez V, et al. Oncoguia: Cancer de Mama. Mexico City: Instituto Nacional de Cancerologia; 2011:77-86.
- Robles-Castillo J, Ruvalcaba-Limon E, Maffuz A, Rodriguez-Cuevas S. Breast cancer in Mexican women under 40. Ginecol Obstet Mex 2011;79:482-8.
- Bonacina R, Mariani U, Villa F, Villa A. Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: a review of 282 patients. J Can Dent Assoc 2011;77:b147.
- Junquera LM, Martin-Granizo R. Diagnostico, prevencion y tratamiento de la osteonecrosis de los maxilares por bisfosfonatos. Recomendaciones de la Sociedad Española de Cirugia Oral y Maxilofacial (SECOM). Rev Esp Cir Oral y Maxilofac 2008;30:145-56.
- Khamaisi M, Regev E, Yarom N, Avni B, Leitersdorf E, Raz I, et al. Possible association between diabetes and bisphosphonaterelated jaw osteonecrosis. J Clin Endocrinol Metab 2007;92:1172-5. https://doi.org/10.1210/jc.2006-2036
- Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update. J Oral Maxillofac Surg 2009;67(5 Suppl):2-12. https://doi.org/10.1016/S0278-2391(09)01877-1
- Fuentes R, Borie E, Sanhueza Campos A, Rebolledo Soto K, Parra Villagran P. Presencia de exostosis orales en pacientes de la ciudad de Temuco, Chile. Avances Odontoestomatol 2012;28:63-9. https://doi.org/10.4321/S0213-12852012000200002
- de la Fuente-Hernandez J, Gonzalez de Cossio M, Ortega-Maldonado M, Sifuentes-Valenzuela MC. Caries y perdida dental en estudiantes preuniversitarios mexicanos [Dental decay and tooth loss at the high school level in Mexican students]. Salud Publica Mex 2008;50:235-40.
Cited by
- Bisphosphonate-related osteonecrosis of the jaw (BRONJ) in cancer patients vol.101, pp.2, 2020, https://doi.org/10.17816/kmj2020-226
- Prevalence and risk factors of medication-related osteonecrosis of the jaw in osteoporotic and breast cancer patients: a cross-sectional study vol.28, pp.5, 2016, https://doi.org/10.1007/s00520-019-05044-0